Dongwang Yan

3.1k total citations
48 papers, 2.3k citations indexed

About

Dongwang Yan is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Dongwang Yan has authored 48 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 22 papers in Cancer Research and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Dongwang Yan's work include Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (12 papers) and MicroRNA in disease regulation (9 papers). Dongwang Yan is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (12 papers) and MicroRNA in disease regulation (9 papers). Dongwang Yan collaborates with scholars based in China, United States and Thailand. Dongwang Yan's co-authors include Huamei Tang, Ben Yue, Chongzhi Zhou, Chenchen Liu, Senlin Zhao, Zhihai Peng, Guoqiang Qiu, Changyi Fang, Zhihai Peng and Zhihai Peng and has published in prestigious journals such as Nature Communications, PLoS ONE and Oncogene.

In The Last Decade

Dongwang Yan

46 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongwang Yan China 27 1.8k 1.3k 458 239 209 48 2.3k
Zhihai Peng China 23 1.3k 0.7× 937 0.7× 325 0.7× 183 0.8× 175 0.8× 33 1.8k
Yang Zhao China 35 2.8k 1.6× 2.1k 1.7× 423 0.9× 145 0.6× 205 1.0× 138 3.5k
Huamei Tang China 34 2.1k 1.2× 1.2k 1.0× 656 1.4× 378 1.6× 201 1.0× 83 2.9k
Meysam Moghbeli Iran 28 1.5k 0.8× 881 0.7× 500 1.1× 176 0.7× 134 0.6× 136 2.1k
Zhihai Peng China 23 1.2k 0.6× 614 0.5× 325 0.7× 211 0.9× 144 0.7× 76 1.8k
Youngsoo Kim United States 19 2.4k 1.3× 1.9k 1.5× 314 0.7× 106 0.4× 214 1.0× 38 2.9k
Zhengsheng Wu China 27 1.5k 0.8× 953 0.8× 683 1.5× 111 0.5× 193 0.9× 69 2.3k
Yulong Shang China 22 1.2k 0.7× 761 0.6× 309 0.7× 96 0.4× 267 1.3× 55 1.8k
Nijiro Nohata Japan 39 3.1k 1.7× 2.6k 2.1× 393 0.9× 190 0.8× 110 0.5× 62 3.7k
Chongzhi Zhou China 24 1.2k 0.7× 623 0.5× 526 1.1× 280 1.2× 79 0.4× 55 1.8k

Countries citing papers authored by Dongwang Yan

Since Specialization
Citations

This map shows the geographic impact of Dongwang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwang Yan more than expected).

Fields of papers citing papers by Dongwang Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwang Yan. The network helps show where Dongwang Yan may publish in the future.

Co-authorship network of co-authors of Dongwang Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwang Yan. A scholar is included among the top collaborators of Dongwang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwang Yan. Dongwang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Menghua, Qi Gu, Yuhai Liu, et al.. (2025). Extensive study on the associations of 12 composite inflammatory indices with colorectal cancer risk and mortality: a cross-sectional analysis of NHANES 2001–2020. International Journal of Surgery. 111(11). 7559–7575. 3 indexed citations
3.
Guan, Bingjie, Bowen Xie, Senlin Zhao, et al.. (2024). Mitochondrial genome transfer drives metabolic reprogramming in adjacent colonic epithelial cells promoting TGFβ1-mediated tumor progression. Nature Communications. 15(1). 3653–3653. 23 indexed citations
4.
Guan, Bingjie, et al.. (2023). Tumor-derived extracellular vesicles delivering TNF-α promotes colorectal cancer metastasis via the NF-kB/LAMB3/AKT axis by targeting SNAP23. Archives of Biochemistry and Biophysics. 741. 109605–109605. 9 indexed citations
5.
Zhao, Senlin, Bingjie Guan, Yushuai Mi, et al.. (2021). LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit. Oncogene. 40(28). 4709–4724. 70 indexed citations
6.
Chen, Jian, Chao Xiao, Xiao Wang, et al.. (2021). The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy. Oncogene. 40(23). 3974–3988. 41 indexed citations
7.
Zhuang, Meng, Senlin Zhao, Zheng Jiang, et al.. (2019). MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. EBioMedicine. 41. 286–298. 91 indexed citations
8.
Zhuang, Meng, Senlin Zhao, Zheng Jiang, et al.. (2018). MALAt1 Sponges miR-106b-5p to Promote the Invasion and Metastasis of Colorectal Cancer via SLAIN2 Enhanced Microtubules Mobility. SSRN Electronic Journal. 2 indexed citations
9.
Zhao, Senlin, Hongcheng Sun, Weiliang Jiang, et al.. (2017). miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition. Molecular Cancer. 16(1). 12–12. 66 indexed citations
10.
Wang, Ye, et al.. (2016). Histone deacetylase enzyme silencing using shRNAs enhances radiosensitivity of SW579 thyroid cancer cells. Molecular Medicine Reports. 14(4). 3509–3516. 7 indexed citations
11.
Liu, Chenchen, Ben Yue, Chenwei Yuan, et al.. (2015). Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer. Biochemical and Biophysical Research Communications. 468(1-2). 53–58. 13 indexed citations
12.
Jiang, Tao, Huamei Tang, Su Lu, et al.. (2013). Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer. Medical Oncology. 30(4). 715–715. 35 indexed citations
13.
Jiang, Tao, Huamei Tang, Zehua Wu, et al.. (2013). Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Medical Oncology. 30(2). 534–534. 45 indexed citations
14.
Fan, Junwei, Dongwang Yan, Mujian Teng, et al.. (2011). Digital Transcript Profile Analysis with aRNA-LongSAGE Validates FERMT1 As a Potential Novel Prognostic Marker for Colon Cancer. Clinical Cancer Research. 17(9). 2908–2918. 22 indexed citations
15.
Li, Dawei, Zhihai Peng, Huamei Tang, et al.. (2011). KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis. Clinical Cancer Research. 17(11). 3558–3568. 94 indexed citations
16.
Sun, Hongcheng, Mujian Teng, Jie Liu, et al.. (2011). FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria. Cancer Letters. 306(2). 214–222. 55 indexed citations
17.
Li, Dawei, Xiao Peng, Dongwang Yan, et al.. (2011). Msi-1 is a Predictor of Survival and a Novel Therapeutic Target in Colon Cancer. Annals of Surgical Oncology. 18(7). 2074–2083. 54 indexed citations
18.
Wang, Quan, Yugang Wen, Dapeng Li, et al.. (2010). Upregulated INHBA expression is associated with poor survival in gastric cancer. Medical Oncology. 29(1). 77–83. 188 indexed citations
19.
Li, Dawei, Dongwang Yan, Huamei Tang, et al.. (2009). IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis. Annals of Surgical Oncology. 16(12). 3499–3506. 94 indexed citations
20.
Li, Dawei, Huamei Tang, Junwei Fan, et al.. (2009). Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. Journal of Cancer Research and Clinical Oncology. 136(7). 997–1006. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026